Consensus EPS · Q4 2026
$0.23
Consensus revenue · Q4 2026
$2.2B
Analysts
2
Expected report
Aug 5, 2026
What to watch
- Analyst ratings: Mixed
Analyst consensus
Based on estimates from 2 analysts.
| Metric | Low | Consensus | High |
|---|---|---|---|
| Revenue | $2.2B | $2.2B | $2.3B |
| EPS | $0.20 | $0.23 | $0.26 |
| EBITDA | $415.6M | $423.2M | $430.8M |
| EBIT | $346.5M | $352.9M | $359.2M |
| Net income | $90.6M | $126.9M | $157.1M |
- Revenue$2.2B
- EPS$0.23
- EBITDA$423.2M
- EBIT$352.9M
- Net income$126.9M
Historical beat/miss
Actual reported results vs. analyst consensus at the time. Positive = beat, negative = miss.
| Period | Rev. actual | Rev. est. | Rev. surprise | EPS actual | EPS est. | EPS surprise |
|---|---|---|---|---|---|---|
| Q3 2026 | $2.2B | $2.1B | +3.4% | $0.21 | $0.19 | +11.5% |
- Q3 2026+3.4%+11.5%
Estimate revisions
How analyst consensus estimates have changed over the past 90 days.
Revision trends appear once we have collected at least two daily snapshots for this period.
Community vs analysts
See how the TickerLeague crowd's forecast stacks up against Wall Street.
Be the first to predict
No community consensus for News (NWSA) Q4 2026 yet. Make a prediction to start the crowd forecast.
Analyst price target
Based on price targets from 0 analysts.
- Low
- $29.40
- Consensus
- $31.70
- Median
- $31.70
- High
- $34.00
- Current
- $27.34
- Upside
- +15.9%
Upside calculated vs most recent trading price of $27.34.
Analyst ratings
Consensus: Buy — based on 28 analyst ratings.
24-month trend
Recent analyst actions
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| May 13, 2026 | Citigroup | maintain | Buy | Buy |
| May 11, 2026 | Macquarie | upgrade | Neutral | Outperform |
| Feb 9, 2026 | Citigroup | maintain | Buy | Buy |
| Nov 25, 2025 | JP Morgan | maintain | Overweight | Overweight |
| Nov 13, 2025 | Guggenheim | maintain | Buy | Buy |
| Aug 20, 2025 | JP Morgan | maintain | Overweight | Overweight |
| Aug 6, 2025 | Macquarie | downgrade | Outperform | Neutral |
| Apr 11, 2025 | Morgan Stanley | maintain | Overweight | Overweight |
| Feb 4, 2025 | UBS | upgrade | Neutral | Buy |
| Jan 22, 2025 | Guggenheim | maintain | Buy | Buy |
- May 13, 2026CitigroupBuy
- May 11, 2026MacquarieOutperform
- Feb 9, 2026CitigroupBuy
- Nov 25, 2025JP MorganOverweight
- Nov 13, 2025GuggenheimBuy
- Aug 20, 2025JP MorganOverweight
- Aug 6, 2025MacquarieNeutral
- Apr 11, 2025Morgan StanleyOverweight
- Feb 4, 2025UBSBuy
- Jan 22, 2025GuggenheimBuy
Frequently asked questions
News (NWSA) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation
How this company returns cash to shareholders — buybacks, dividends, and stock splits.